Inventors:
Christopher Blackburn - Natick MA, US
Su-Jen Lai - Somerville MA, US
Jennifer Che - Cambridge MA, US
Martin Maguire - Woburn MA, US
Michael Patane - Andover MA, US
Matthew LaMarche - Reading MA, US
Courtney Cullis - Belmont MA, US
James Brown - Framingham MA, US
Anil Vasudevan - Gurnee IL, US
Jennifer Freeman - Grayslake IL, US
Mathew Mulhern - Hainesville IL, US
John Lynch - Kenosha WI, US
Ju Gao - Gurnee IL, US
Dariusz Wodka - Waukegan IL, US
Andrew Souers - Evanston IL, US
Rajesh Iyengar - Lindenhurst IL, US
Mary Verzal - Burlington WI, US
Philip Kym - Grayslake IL, US
Assignee:
Millennium Pharmaceuticals, Inc.
International Classification:
A61K031/4545, A61K031/452, C 07D 4 5/02, C 07D 4 1/02
US Classification:
514/317000, 514/318000, 514/326000, 546/194000, 546/207000
Abstract:
This invention provides compounds that are antagonists of melanin concentrating hormone receptor-1 (MCH-R1). The compounds are represented by formula I:
where m is zero or one, n is zero to two, Y is oxygen or —N(R)—, R, R, R, R, R, Rand Ring A are defined in the specification. Coumarin and quinolone compounds where Rand Rtogether form a fused benzo ring are preferred. The invention also provides compounds of formula VI where the coumarin moiety is replaced by a quinazolinone ring. The compounds are useful for treating MCH-R1-related disorders, particularly overweight conditions including obesity.